Please login to the form below

Not currently logged in
Email:
Password:

Sanofi and T1D Exchange collaborate to understand needs of children living with diabetes

Aims to deliver recommendations for better disease management and patient outcomes

Sanofi and T1D Exchange

Sanofi is to work with non-profit organisation T1D Exchange in a global research collaboration to better understand the needs of children and young people living with type 1 diabetes.

Launched the same week as World Diabetes Day, the TEENs registry study aims to gain deeper knowledge of this young diabetes community in order to deliver recommendations for better disease management and patient outcomes.

The study will enroll more than 7,000 people across 20 countries. Participants will be aged between 8 and 25 and have type 1 diabetes.

The primary outcome to be measured by Sanofi and T1D is the percentage of patients with controlled glycaemia, as measured by haemoglobin A1c (HbA1c).

Secondary outcomes of note include quality of life and emotional status; the relationship between glycaemic control and quality of life; and the impact of factors such as medical care on these measurements.

“To better understand how to treat young people with type 1 diabetes, we need to know how exactly they are living with the disease,” said Riccardo Perfetti, VP medical affairs, global diabetes, Sanofi.

“Our goal with the TEENs study is to examine how clinical factors such as glycemic control impact the quality of life of this particularly vulnerable group of young people with diabetes.”

T1D, which aims to accelerate the discovery of new research approaches within type 1 diabetes, will support the study in the US, assisting Sanofi in the recruitment of trial participants using its patient registry and connections with clinics.

Outside the US, Sanofi will work with clinic centres, hospitals and healthcare professionals.

The French pharma company said it hopes to identify predictive factors for glucose control and acute complications of type 1 diabetes; gain a better understanding of unmet needs of young people with type 1 diabetes in different age groups; and to document insulin regimens of this group.

In addition, Sanofi said it expects to develop a description of the difficult journey from paediatric to adult care services.

Results from the TEENs study will be presented at scientific congresses in 2013 and in 2014.

16th November 2012

From: Research, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics